Articles
Tackling Mycoplasma Contamination in Biotherapeutic Production
Detect mycoplasma faster with sensitive DNA-based qPCR workflows designed to strengthen biotherapeutic quality control
GLOBAL ONLINE BULK AUCTION ONE LOT SALE! One Money Bid - Winning Bidder Wins All Items
Heritage Global Partners (HGP) is a leading, full service, global auction and asset advisory firm. HGP’s management team brings over 150 years of collective industry experience and expertise in virtually every industrial sector and geography.
Cubics II MCA 21 CFR Part 11 Compliance Checklist
The Cubis® II balance, with pharma package, contains all the technical controls to support compliance with common regulations
Stay Up-to-Date with Everything Live-Cell
The new generation of live-cell analysis technologies are allowing scientists to capture dynamic insights using non-perturbing, long-term cell studies.
Advancing Innovation in Drug Development and Patient Care
At Certara, we are innovators, dedicated to helping our clients develop new therapies and target unmet medical needs, expand existing therapies to other subpopulations
RapID Raw Material ID Verification System
The RapID Raman system is the next generation in raw material testing, a crucial component of pharmaceutical quality control at GMP facilities
Analytical strategies for sterility and mycoplasma testing in biotherapies
Characterization of a biological product, including the determination of product safety and impurities, is necessary for regulatory compliance, along with patient safety
The BioFlo® 320
Bioprocess Solutions for Cell Therapy Development
Streamline scale-up and reduce time to market with Gibco CHO solutions
An Insider Perspective Key Considerations When Scaling Up Media Manufacturing
Five Factors that will drive growth in the Indian pharma sector in 2023
NSF Vice President Sanjay Shetgar looks at five issues driving growth in the Indian pharmaceutical sector in 2023. He considers how proactive quality management, training and education, agile regulatory management, and other elements will drive the success of the world's third- largest pharmaceutical industry.




